After reviewing the provided sources, there is no specific information about the minimum quantity for bulk Vascepa purchases.

DrugPatentWatch [1] provides general information about the Vascepa drug, including its active ingredient, patents, and exclusivity. However, it does not mention any information about the minimum quantity for bulk purchases.

The article published in the National Center for Biotechnology Information [2] discusses the effectiveness of Vascepa in reducing cardiovascular events. It provides clinical trial data and highlights the benefits of Vascepa as a treatment option for patients with cardiovascular disease. However, the article does not mention anything about the minimum quantity for bulk purchases.

The European Medicines Agency [3] provides a comprehensive assessment report for Vazkepa, which is the European brand name for Vascepa. The report includes information about the drug's quality, safety, and efficacy. However, it does not provide any information about the minimum quantity for bulk purchases.

In conclusion, based on the provided sources, there is no information available about the minimum quantity for bulk Vascepa purchases. It is recommended to contact the manufacturer or supplier directly for more information.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671468/
[3] https://www.ema.europa.eu/en/documents/assessment-report/vazkepa-epar-public-assessment-report_en.pdf